MY208035A - Emulsion formulation and method for preparing the same - Google Patents

Emulsion formulation and method for preparing the same

Info

Publication number
MY208035A
MY208035A MYPI2021002338A MYPI2021002338A MY208035A MY 208035 A MY208035 A MY 208035A MY PI2021002338 A MYPI2021002338 A MY PI2021002338A MY PI2021002338 A MYPI2021002338 A MY PI2021002338A MY 208035 A MY208035 A MY 208035A
Authority
MY
Malaysia
Prior art keywords
emulsion formulation
preparing
provides
same
peptides
Prior art date
Application number
MYPI2021002338A
Inventor
Yusuke Doi
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MY208035A publication Critical patent/MY208035A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/65—Mixers with shaking, oscillating, or vibrating mechanisms the materials to be mixed being directly submitted to a pulsating movement, e.g. by means of an oscillating piston or air column
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

This invention provides a water-in-oil (w/o) emulsion formulation that stably contains 3 types of peptides having 4 linked CTL epitopes. This invention also provides a method for efficiently preparing the w/o emulsion formulation containing 3 types of peptides having 4 linked CTL epitopes. This invention provides a w/o emulsion formulation that stably contains 3 types of peptides having 4 linked CTL epitopes and a method for efficiently preparing such w/o emulsion formulation. In addition, this invention provides an improved method and an apparatus to prepare such emulsion formulation. (FIG. 1)
MYPI2021002338A 2018-11-02 2019-11-01 Emulsion formulation and method for preparing the same MY208035A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018207779 2018-11-02
PCT/JP2019/043023 WO2020091040A1 (en) 2018-11-02 2019-11-01 Emulsion preparation and preparation method thereof

Publications (1)

Publication Number Publication Date
MY208035A true MY208035A (en) 2025-04-10

Family

ID=70463271

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021002338A MY208035A (en) 2018-11-02 2019-11-01 Emulsion formulation and method for preparing the same

Country Status (15)

Country Link
US (1) US20210401745A1 (en)
EP (1) EP3878463A4 (en)
JP (1) JP7508371B2 (en)
KR (1) KR102718933B1 (en)
CN (1) CN112955173A (en)
AU (1) AU2019369845A1 (en)
BR (1) BR112021008172A2 (en)
CA (1) CA3118417A1 (en)
MA (1) MA54182A (en)
MX (1) MX2021004826A (en)
MY (1) MY208035A (en)
PH (1) PH12021550993A1 (en)
SG (1) SG11202104416YA (en)
TW (1) TW202033181A (en)
WO (1) WO2020091040A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3815711A4 (en) 2018-06-29 2022-08-10 Taiho Pharmaceutical Co., Ltd. ANTITUMOR AGENT AND ITS METHOD OF EVALUATION
CN115738778B (en) * 2022-10-24 2025-10-31 广东广纳安疗科技有限公司 Emulsion preparation facilities
WO2025185814A1 (en) * 2024-03-05 2025-09-12 Möller Medical Gmbh System for automated biological sample processing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5847650Y2 (en) 1979-08-13 1983-10-31 シャープ株式会社 rechargeable electrical equipment
JPWO2007083763A1 (en) * 2006-01-23 2009-06-11 株式会社グリーンペプタイド Method for preparing emulsion preparation of bioactive peptide and kit for preparing the preparation
AU2009287565B2 (en) 2008-09-05 2014-08-07 Oncotherapy Science, Inc. Device and method for automatically preparing emulsion drug
HUE050164T2 (en) * 2013-10-21 2020-12-28 Taiho Pharmaceutical Co Ltd Novel four-ctl epitope-joined peptide
JP2018207779A (en) 2018-09-20 2018-12-27 株式会社ニコン Vibration actuator, lens barrel and camera

Also Published As

Publication number Publication date
JPWO2020091040A1 (en) 2021-09-30
EP3878463A1 (en) 2021-09-15
KR20210084584A (en) 2021-07-07
AU2019369845A1 (en) 2021-05-27
CA3118417A1 (en) 2020-05-07
WO2020091040A1 (en) 2020-05-07
BR112021008172A2 (en) 2021-08-17
PH12021550993A1 (en) 2021-10-04
EP3878463A4 (en) 2022-12-07
KR102718933B1 (en) 2024-10-18
CN112955173A (en) 2021-06-11
US20210401745A1 (en) 2021-12-30
MX2021004826A (en) 2021-06-15
SG11202104416YA (en) 2021-05-28
MA54182A (en) 2021-09-15
JP7508371B2 (en) 2024-07-01
TW202033181A (en) 2020-09-16

Similar Documents

Publication Publication Date Title
GB2547360A (en) Image reconstruction system and method
SG10201805290YA (en) System and method for evaluation of used components
CL2020000938A1 (en) Anti-tigit antibodies, their compositions and use. (divisional request 201800744)
TN2019000272A1 (en) Anti-ilt4 antibodies and antigen-binding fragments.
MX389573B (en) Listeria-based compositions comprising a peptide minigene expression system and methods of using the same.
MX2020002241A (en) Anti-tm4sf1 antibodies and methods of using same.
MY194603A (en) Anti-Complement Factor Bb Antibodies And Uses Thereof
PH12021550993A1 (en) Emulsion formulation and method for preparing the same
EP4324481A3 (en) Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
JOP20210326A1 (en) Natriuretic peptide receptor 1 antibodies and methods of use
PH12020550340A1 (en) Anti-pacap antibody
ES2722773T3 (en) Modified Meningococcal fHbp Polypeptides
WO2015166105A3 (en) Ion channel modulators and uses thereof
MX2020014205A (en) Use of multiple hydrophobic interaction chromatography for preparing a polypeptide from a mixture.
MX391005B (en) New methods for epitope selection
SA518400221B1 (en) Pressure-Regulating Device, Systems Including The Pressure-Regulating Device, and Related Methods
WO2018189661A3 (en) Methods and compounds for treating diabetes
EA202091095A1 (en) ORAL DELIVERY OF GLP-1 PEPTIDE ANALOGUES
SG10201805841PA (en) Method and device for producing an electronic signed document
SG10201901275PA (en) Storage device and server including the storage device
WO2019094533A8 (en) Angptl8-binding agents and methods of use thereof
SA521422309B1 (en) Feline mcdonough sarcoma-like tyrosine kinase 3 agonist antibodies and uses thereof
WO2016011432A3 (en) Identification of immunogenic mhc class ii peptides for immune-based therapy
MX2018010061A (en) Multigenome retroviral vector preparations and methods and systems for producing and using same.
MX2018015362A (en) Method for producing a container.